Products
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$13.5/mo
Lower than 60% of peersNiche median $19/mo
Creators
Adib Istanbouli
No social account linked
Launched
10mo ago
2026-01-26 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Elevate Your Risk Analysis

    Jan 26 · 10mo agoLaunch page

MCP Server & Agent Ecosystem

GitHub · MCP / Skill

Agent, MCP & Developer Integration

MCP Server
Ecosystem & integrations:
ClaudeChatGPT
Browse all MCP Server products →

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2019-12-22

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
€0
1 list · 20 symbols per list
PRO
€19.99 / €149.99
Up to 10 watchlists

Trial: None · Observed 2026-11-10 · Pricing page

Entry price $13.5/mo, Lower than 60% of peers; “Financial Data & Research” median is $19/mo.View pricing benchmark

Website snapshots

Indexed 2026-01-26

Key pages

Desktop & mobile archive
markets.capital/ Snapshot 2026-11-10

Questions & evidence

How much does Markets Capital cost?
Free: €0; PRO: €19.99 / €149.99. Observed 2026-11-10. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Markets Capital get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Markets Capital and what platforms does it support?
Markets Capital is catalogued under Financial Data & Research: See the move.Know the why. Supported platforms: Mobile App, MCP Server.

Related products in this category

Finance / Financial Data & Research

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.